Author: Gootz, Thomas D

Source: Expert Review of Anti-Infective Therapy, Volume 2, Number 2, April 2004 , pp. 317-327(11)

Publisher: Expert Reviews

Abstract:

While the main era of β-lactam discovery programs is over, these agents continue to be the most widely prescribed antimicrobials in both community and hospital settings. This has led to considerable β-lactam pressure on pathogens, resulting in a literal explosion of new β-lactamase variants of existing enzyme classes. Recent advances in the molecular tools used to detect and characterize β-lactamases and their genes has, in part, fueled the large increase in communications identifying novel β-lactamases, particularly in Gram-negative bacilli. It now seems clear that the β-lactams themselves have shaped the field of new enzymes, and the evolution of key amino acid substitutions around the active sites of β-lactamases continues to drive resistance. Over 130 variants of TEM β-lactamase now exist, and more are reported in the scientific literature each month. The most disturbing current trend is that many bla structural genes normally limited to the chromosome are now mobilized on plasmids and integrons, broadening the spread of resistance to include carbapenems and cephamycins. Furthermore, in some Enterobacteriaceae, concomitant loss of outer membrane porins act in concert with these transmissible β-lactamase genes to confer resistance to the most potent β-lactams and inhibitor combinations available. Continued reviews of the literature are necessary in order to keep abreast of the ingenuity with which bacteria are changing the current genetic landscape to confer resistance to this important class of antimicrobials.

Keywords: ambler class A, B, C and D β2-lactamases; β2-lactamases; carbapenemase; Escherichia coli; extended spectrum β2-lactamases; Klebsiella pneumoniae; OXA; SHV; TEM; third-generation cephalosporins

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14787210.2.2.317

Publication date: 2004-04-01

More about this publication?

• Expert Review of Anti-infective Therapy provides expert reviews on therapeutics and diagnostics in the treatment of infectious disease. Coverage includes antibiotics, drug resistance, drug therapy, infectious disease medicine, antibacterial, antimicrobial, antifungal and antiviral approaches, and diagnostic tests.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• Free Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Microbiology ,  Medicine ,  Medicine (General)
• By this author: Gootz, Thomas D

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers